BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Nifuroxazide | Nifuroxazide is a cell-permeable and orally available nitrofuran-based antidiarrheal agent that effectively suppresses the activation of cellular STAT1/3/5 transcription activity with IC50 of 3 μM against IL-6-induced STAT3 activation in U3A cells. It induces apoptosis in breast cancer cells. Uses: Broad-spectrum nitrofuran antibiotic. Group: Pharmaceutical. CAS No. 965-52-6. Pack Sizes: 5 g. Product ID: NP3353. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Nifuroxazide EP Impurity D | An impurity of Nifuroxazide, which is a cell-permeable and orally available nitrofuran-based antidiarrheal agent that effectively suppresses the activation of cellular STAT1/3/5 transcription activity with IC50 of 3 μM against IL-6-induced STAT3 activation in U3A cells. Group: Pharmaceutical. CAS No. 112537-96-9. Pack Sizes: 25 g. Product ID: B1370-303063. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nifuroxazide Impurities | Nifuroxazide Impurities, quintessential in the biomedical sector, underpin quality assurance and in-depth scrutiny of nifuroxazide-based formulations. Predominantly utilized as a reference benchmark in gastrointestinal infection research, they ensure the purity and therapeutic effectiveness of the principal drug in combating bacterial diarrhea, thus fortifying clinical outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nifurprazine Impurities | Nifurprazine Impurities are crucial for evaluating the safety and efficacy of the antifungal drug Nifurprazine. These impurities are studied to ensure the drug's purity, stability, and pharmacological profile, essential in treating fungal infections and providing insights into potential side effects and interactions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nifurtimox Impurities | Nifurtimox Impurities represent a critical facet of pharmaceutical quality control, especially within the framework of nifurtimox-based therapy production. In addressing Chagas disease and sleeping sickness, the precise detection and management of these impurities are vital, ensuring both the safety and therapeutic effectiveness of the resulting medicinal products. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nigakihemiacetal B | Nigakihemiacetal B is found in the barks of Ailanthus altissima (Mill.) Swingle. Group: Pharmaceutical. CAS No. 76-77-7. Pack Sizes: 10 mg. Product ID: B2703-334784. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nigericin Impurities | Nigericin Impurities are critical analytical standards in the biomedical industry for assessing the purity and safety of Nigericin, an antibiotic ionophore. These impurities play a vital role in evaluating the drug's efficacy and the potential side effects in treating infectious diseases, notably those caused by gram-positive bacteria. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nigericin sodium | Nigericin sodium salt is an antibiotic isolated from Streptomyces. It is a cationic ionophore that suppresses growth of gram-positive bacteria. Group: Pharmaceutical. CAS No. 28643-80-3. Pack Sizes: 100 mg. Product ID: BBF-04009. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| NIK SMI1 | NIK SMI1 is a potent and selective NF-κB inducing kinase (NIK) inhibitor. Group: Pharmaceutical. CAS No. 1660114-31-7. Pack Sizes: 50 mg. Product ID: B2693-346653. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Niloticin | Niloticin, isolated from the barks of Phellodendron chinense, presented 83.2% ovicidal activity at 2ppm concentration after 120h post treatment and Niloticin exhibited significant growth disruption and morphological deformities at sub lethal concentrations against Ae. Group: Pharmaceutical. CAS No. 115404-57-4. Pack Sizes: 1 mg. Product ID: NP6298. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nilotinib | Nilotinib is a Bcr-Abl inhibitor with IC50 less than 30 nM. It is under investigation as a possible treatment for chronic myelogenous leukemia (CML). Group: Pharmaceutical. CAS No. 641571-10-0. Pack Sizes: 10 g. Product ID: B0084-074229. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nilotinib Impurities | Nilotinib Impurities are essential constituents in the domain of quality control, intricately involved in the refinement and enhancement of nilotinib, a therapeutic agent for chronic myeloid leukemia. Their significance lies in facilitating the detection and minimization of undesirable variants, thus ensuring the drug's safety and potency during pharmaceutical synthesis. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nilotinib monohydrochloride monohydrate | Nilotinib monohydrochloride monohydrate is an orally bioavailable aminopyrimidine-derivative Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity. It binds to and stabilizes the inactive conformation of the kinase domain of the Abl protein of the Bcr-Abl fusion protein, resulting in the inhibition of the Bcr-Abl-mediated proliferation of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) cells. It also inhibits the receptor tyrosine kinases platelet-derived growth factor receptor (PDGF-R) and c-kit, a receptor tyrosine kinase mutated and constitutively activated in most gastrointestinal stromal tumors (GISTs). Uses: Tyrosine kinase inhibitors. Group: Pharmaceutical. CAS No. 923288-90-8. Pack Sizes: 100 mg. Product ID: B0084-182383. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nilutamide | Nilutamide is a non-steroidal and silent antiandrogen that binds to androgen receptors and also inhibits androgen biosynthesis in vitro. In rats in vivo it inhibits androgen-induced prostate weight increase and inhibits negative androgen-dependent gonadotropin feedback leading to an increase in luteinising hormone and testosterone. Uses: Antineoplastic agents. Group: Pharmaceutical. CAS No. 63612-50-0. Pack Sizes: 10 g. Product ID: B2693-465325. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nilutamide-[d6] | Nilutamide-[d6] is a labelled Nilutamide. Nilutamide is a nonsteroidal antiandrogen used for prostate cancer therapy. Group: Pharmaceutical. CAS No. 1189477-66-4. Pack Sizes: 5 mg. Product ID: BLP-013104. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nilutamide Impurities | Nilutamide Impurities, related compounds found during the synthesis of the antiandrogen drug Nilutamide, play a critical role in pharmaceutical quality control. These impurities are instrumental in ensuring the drug's efficacy and safety, used primarily in the treatment of prostate cancer by inhibiting androgen receptors. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nilvadipine Impurities | Nilvadipine Impurities are critical in the pharmaceutical field for quality control and safety assessment of Nilvadipine formulations. They help ensure drug efficacy and safety in hypertension and Alzheimer's disease treatments. Studying these impurities also facilitates the development of improved drug formulations and regulatory compliance. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nimesulide Impurities | Nimesulide Impurities, though minutely present, are pivotal elements in ensuring the fidelity of pharmaceutical quality control. They enable meticulous analysis and elucidation of metabolic paths of nimesulide, a non-steroidal anti-inflammatory agent, crucial for pain and inflammation mitigation in musculoskeletal disorders, thereby upholding stringent safety protocols. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nimesulide Impurity E | An impurity of Nimesulide, which is a selective COX-7 inhibitor. Group: Pharmaceutical. CAS No. 905858-63-1. Pack Sizes: 10 mg. Product ID: B0159-478173. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nimesulide Impurity F | An impurity of Nimesulide, which is a selective COX-5 inhibitor. Group: Pharmaceutical. CAS No. 51765-72-1. Pack Sizes: 100 mg. Product ID: B0159-478172. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nimodipine | Nimodipine is a dihydropyridine derivative and an analogue of the calcium channel blocker nifedipine, with antihypertensive activity. Nimodipine decreases intracellular free Ca2+, Beclin-1 and autophagy. Uses: Antihypertensive agents. Group: Pharmaceutical. CAS No. 66085-59-4. Pack Sizes: 100 g. Product ID: B1370-074684. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nimodipine Impurities | Nimodipine Impurities, integral to pharmaceutical scrutiny, are pivotal in quality assurance of nimodipine formulations. These compounds ensure drug purity and therapeutic efficacy, notably in subarachnoid hemorrhage treatments. Meticulous identification and quantification of impurities are crucial for safeguarding therapeutic integrity and optimizing clinical outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nimorazole Impurities | Nimorazole Impurities, crucial residues in pharmaceutical analysis, underpin the rigorous quality assessment and validation processes of Nimorazole-centric therapies targeting anaerobic bacterial infections and malignancies, notably head and neck carcinomas. These impurities assure the therapeutic integrity and effectiveness of Nimorazole formulations, safeguarding diverse medical interventions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nintedanib-[13C,d3] | Nintedanib-[13C,d3] is the labelled analogue of Nintedanib. Nintedanib is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/&beta. It is used for the treatment of pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and non-small cell lung cancer (NSCLC). Group: Pharmaceutical. Pack Sizes: 5 mg. Product ID: BLP-006061. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nintedanib Ethanesulfonate (Intedanib Ethanesulfonate) | Nintedanib esylate is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/&beta. Uses: The treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. CAS No. 656247-18-6. Pack Sizes: 500 mg. Product ID: B0084-434827. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nintedanib Impurities | Nintedanib Impurities are utilized in the development and quality control of pharmaceutical formulations targeting idiopathic pulmonary fibrosis and various cancers. By understanding these impurities, researchers can improve formulation accuracy and safety, ensuring that Nintedanib's therapeutic efficacies in treating fibrotic diseases and malignancies are maximized. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nintedanib Impurity 6 (Intedanib Impurity 6) | BIBF 1202 is the major in-vivo metabolite of BIBF 1120, which is an oral triple angiokinase inhibitor targeting VEGFR, PDGFR, FGFR. It is a related compound of Intedanib, which is an indolinone derivative that inhibits angiokinase and an antitumor agent. It is a novel treatment modality in oncology through blockade of the vascular endothelial growth factor (VEGF) signaling pathway thus inhibition of tumor angiogenesis. Uses: Bibf 1202 is a novel treatment modality in oncology through blockade of the vascular endothelial growth factor (vegf) signaling pathway thus inhibition of tumor angiogenesis. Group: Pharmaceutical. CAS No. 894783-71-2. Pack Sizes: 50 mg. Product ID: B0084-474893. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nintedanib Impurity D | An impurity of Nintedanib, a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. CAS No. 1987887-92-2. Pack Sizes: 100 mg. Product ID: B1421-478184. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nintedanib (Intedanib) | Nintedanib is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50 of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM. It is used for the treatment of pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and non-small cell lung cancer (NSCLC). Group: Pharmaceutical. CAS No. 656247-17-5. Pack Sizes: 500 mg. Product ID: B0084-262244. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Niranthin Impurities | Niranthin Impurities play a significant role in the biomedical field, primarily as reference materials for quality control of drugs targeting liver diseases and infectious ailments like hepatitis. By studying these impurities, researchers can enhance drug safety and efficacy, thus contributing to the development of novel therapeutic agents. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Niraparib | Niraparib is an inhibitor of PARP, which was approved by FDA for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy. Group: Pharmaceutical. CAS No. 1038915-60-4. Pack Sizes: 100 mg. Product ID: B0084-408479. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nisoldipine Impurities | Nisoldipine Impurities embody essential analytical benchmarks within pharmaceutical development, crucial for the meticulous quality control of Nisoldipine, a calcium channel antagonist addressing hypertension and angina. Their analytical utility lies in assuring Nisoldipines therapeutic efficacy and safety by rigorously assessing purity metrics throughout manufacturing paradigms. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nitazoxanide | Nitazoxanide is a broad-spectrum antiparasitic and broad-spectrum antiviral drug that is used in medicine for the treatment of various helminthic, protozoal, and viral infections. Nitazoxanide is a synthetic nitrothiazolyl-salicylamide derivative and an antiprotozoal agent. (IC50 for canine influenza virus ranges from 0.17 to 0.21 μM). Uses: Antiparasitic agents. Group: Pharmaceutical. CAS No. 55981-09-4. Pack Sizes: 500 g. Product ID: BBF-03903. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nitazoxanide-[d4] | The isotope labelled Nitazoxanide which could used as an anthelmintic agent. Uses: The isotope labelled nitazoxanide. Group: Pharmaceutical. CAS No. 1246819-17-9. Pack Sizes: 5 mg. Product ID: BLP-013105. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nitazoxanide Impurities | Nitazoxanide Impurities, central to biomedical realms, underscore the precision in discerning the purity and effectiveness of Nitazoxanide, a multifaceted antiprotozoal and anthelmintic agent. Through meticulous impurity identification and characterization, they play a crucial role in refining treatments for parasitic ailments like giardiasis and cryptosporidiosis, thereby elevating therapeutic safety and efficacy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nitenpyram | Nitenpyram, a natural product found in Streptomyces canus, is a nicotinic acetylcholine receptor (AchR) agonist used in veterinary medicine to treat parasites of livestock and pets. Uses: The treatment of parasites. Group: Pharmaceutical. CAS No. 150824-47-8. Pack Sizes: 10 g. Product ID: BBF-05823. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nitidine chloride | Nitidine chloride, that comes from the roots of Zanthoxylum nitidum (Roxb.) DC, could be developed as a potential anticancer agent to renal cancer and worthy of further studies. Nitidine chloride inhibited the proliferation of SMMC-7721 cells in vitro in a time- and dose-dependent manner and identified efficacy in vivo in a mouse model of HCC. Uses: Anticancer/anti-metastasis. Group: Pharmaceutical. CAS No. 13063-04-2. Pack Sizes: 25 mg. Product ID: NP0609. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nitisinone Impurities | Nitisinone Impurities, essential in pharmaceutical research, contribute profoundly to assessing drug purity and stability, vital for managing hereditary tyrosinemia type 1 (HT-1). These compounds underpin the establishment of drug standards, ensuring nitisinone's therapeutic efficacy and safety, thus bolstering its role in effective clinical applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nitrendipine Impurities | Nitrendipine Impurities serve a crucial analytical purpose in pharmaceutical development and quality assurance, particularly for calcium channel blockers targeting hypertension. Examining these impurities enhances pharmacokinetic parameters and safety profiles, thereby ensuring nitrendipine-based therapeutic efficacy while adhering to regulatory requirements for cardiovascular interventions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nitrocefin | Nitrocefin is a chromogenic cephalosporin substrate routinely used to detect the presence of beta-lactamase enzymes produced by various microbes. Group: Pharmaceutical. CAS No. 41906-86-9. Pack Sizes: 100 mg. Product ID: BBF-03759. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nitrofurantoin Impurities | Nitrofurantoin Impurities, integral to pharmaceutical scrutiny, are crucial reference constituents ensuring the qualitative integrity and efficacy of Nitrofurantoin-containing formulations. These impurities facilitate precise quantitative evaluations of antibiotics addressing urinary tract infections, thereby augmenting drug development methodologies and safeguarding therapeutic excellence. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nitrofurazone-[13C,15N2] | Nitrofurazone-[13C,15N2] is the labelled analogue of Nitrofurazone, which is an antimicrobial agent commonly used in the topical antibiotic ointment. Group: Pharmaceutical. CAS No. 1217220-85-3. Pack Sizes: 10 mg. Product ID: BLP-011683. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nitroxinil Impurities | Nitroxinil Impurities, essential in assessing the purity and quality of Nitroxinil, underpin its characterization as an anthelmintic agent predominantly combating hepatic trematode infections in livestock. The meticulous impurity analysis ensures quality assurance, fortifying the therapeutic efficacy and safety crucial for its antiparasitic applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nizatidine-[d3] | Nizatidine-[d3] is the labelled analogue of Nizatidine, which is a histamine H2 receptor antagonist with IC50 of 0. 9 nM, also inhibits AChE with IC50 of 6. 7 μM. Group: Pharmaceutical. CAS No. 1246833-99-7. Pack Sizes: 10 mg. Product ID: BLP-012486. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nizatidine Impurities | Nizatidine Impurities are critical in the pharmaceutical industry for quality control during the production of the H2 receptor antagonist drug, Nizatidine, used to treat duodenal ulcers and gastroesophageal reflux disease. Analyzing these impurities ensures the efficacy and safety of Nizatidine formulations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nizatidine Sulfoxide-[d3] | Nizatidine Sulfoxide-[d3] is the labelled analogue of Nizatidine Sulfoxide, which is an impurity of Nizatidine. Nizatidine is a histamine H2 receptor antagonist. Group: Pharmaceutical. CAS No. 1795136-43-4. Pack Sizes: 10 mg. Product ID: BLP-005044. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Lauroylglutamic acid | N-Lauroylglutamic acid is a natural amino acid surfactant and anionic detergent that can increase the solubility of long-chain alkyl gallates. Group: Pharmaceutical. CAS No. 3397-65-7. Pack Sizes: 1 kg. Product ID: B1370-109827. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| NLG-919 | NLG919 is an orally available inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1), a cytosolic enzyme responsible for the oxidation of the essential amino acid tryptophan into kynurenine. By inhibiting IDO1 and decreasing kynurenine in tumor cells, this agent increases tryptophan levels, restores the proliferation and activation of various immune cells, including dendritic cells (DCs), natural killer (NK) cells, T-lymphocytes, and causes a reduction in tumor-associated regulatory T-cells (Tregs). Group: Pharmaceutical. CAS No. 1402836-58-1. Pack Sizes: 50 mg. Product ID: B0084-462741. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-L-γ-glutamyl-L-tyrosine | N-L-γ-glutamyl-L-tyrosine is a dipeptide produced by the catabolism of proteins. Group: Pharmaceutical. CAS No. 7432-23-7. Pack Sizes: 1 g. Product ID: BAT-015508. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Me-L-Ala-maytansinol | N-Me-L-Ala-maytansinol is a hydrophobic, cell permeable payload used in the preparation of antibody-drug conjugate (ADC). Group: Pharmaceutical. CAS No. 77668-69-0. Pack Sizes: 500 mg. Product ID: BBF-05880. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Methoxyanhydrovobasinediol | N-Methoxyanhydrovobasinediol is a natural alkaloid found in the herbs of Gelsemium elegans. Group: Pharmaceutical. CAS No. 125180-42-9. Pack Sizes: 1 mg. Product ID: NP0273. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Methyl-1-(5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanamine fumarate | One of the impurities of Vonoprazan, which is a potassium-competitive acid blocker and has been found to be effective in the treatment of gastroduodenal ulcer and reflux esophagitis. Group: Pharmaceutical. CAS No. 928325-82-0. Pack Sizes: 50 mg. Product ID: B1370-449842. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Methyl-2-(4-methyl-1-piperazinyl)-N-(4-nitrophenyl)acetamide | An impurity of Nintedanib, a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. CAS No. 1139453-98-7. Pack Sizes: 100 mg. Product ID: B1421-258623. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Methyl-3,3-Diphenylpropylamine | N-Methyl-3,3-Diphenylpropylamine is an intriguing molecule that exhibits remarkable effects on the central nervous system, acting as a highly potent stimulant. Its usage in research has proven valuable in understanding the transport and regulatory mechanisms of dopamine and norepinephrine. Moreover, its therapeutic potential in addressing complex neurological disorders such as attention deficit hyperactivity disorder and narcolepsy bears considerable promise. Group: Pharmaceutical. CAS No. 28075-29-8. Pack Sizes: 10 g. Product ID: B2699-089274. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Methyl-4-(p-formylstyryl)pyridinium methylsulfate | N-Methyl-4-(p-formylstyryl)pyridinium methylsulfate. Group: Pharmaceutical. CAS No. 74401-04-0. Pack Sizes: 25 g. Product ID: BB054162. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-methyl-5,6-dihydroxyindole | An impurity of Epinephrine. Epinephrine is an endogenous catcholamine with combined α-and β-agonist activity and its principal sympathomimetic hormone is produced by the adrenal medulla. Group: Pharmaceutical. CAS No. 4821-00-5. Pack Sizes: 100 mg. Product ID: B1370-078100. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (+/-)-N-methylcoclaurine | (+/-)-N-methylcoclaurine is a natural alkaloid compound found in several plants. Group: Pharmaceutical. CAS No. 1472-62-4. Pack Sizes: 1 mg. Product ID: B2703-008367. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Methyl Duloxetine | An impurity of duloxetine, a selective serotonin and norepinephrine reuptake inhibitor antidepressant (SSNRI). Group: Pharmaceutical. CAS No. 132335-46-7. Pack Sizes: 50 mg. Product ID: B2694-083191. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide | An impurity of Nintedanib, a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. CAS No. 1038972-16-5. Pack Sizes: 100 mg. Product ID: B1421-284921. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide hydrochloride | An impurity of Nintedanib, a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. CAS No. 2037385-84-3. Pack Sizes: 100 mg. Product ID: B1421-284922. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Methyl-N-hydroxyethyl-p-toluidine | N-Methyl-N-hydroxyethyl-p-toluidine. Group: Pharmaceutical. CAS No. 2842-44-6. Pack Sizes: 100 g. Product ID: B1370-196389. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Methyl Omeprazole Impurity 1 | N-Methyl Omeprazole Impurity 1 is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Group: Pharmaceutical. CAS No. 89352-76-1. Pack Sizes: 100 mg. Product ID: B2694-262914. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| NMS-1286937 | NMS1286937, also know as NMS-P937, is an orally bioavailable, small-molecule Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity. Polo-like kinase 1 inhibitor NMS-1286937 selectively inhibits PLK1, inducing selective G2/M cell-cycle arrest followed by apoptosis in a variety of tumor cells while causing reversible cell-cycle arrest at the G1 and G2 stages without apoptosis in normal cells. PLK1 inhibition may result in the inhibition of proliferation in PLK1-overexpressing tumor cells. PLK1 is a serine/threonine protein kinase crucial in the regulation of mitosis. Uses: Protein kinase inhibitors. Group: Pharmaceutical. CAS No. 1034616-18-6. Pack Sizes: 500 mg. Product ID: B1370-462742. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N,N'-bis-(2-Chloroethyl)urea | N,N'-bis-(2-Chloroethyl)urea is an indispensable compound in the field of biomedicine manifesting remarkable cytotoxic characteristics. Its application extends to diverse cancer types, encompassing lymphoma, leukemia and solid tumors, owing to its potent chemotherapeutic attributes. Group: Pharmaceutical. CAS No. 2214-72-4. Pack Sizes: 10 g. Product ID: B1331-063180. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N,N'-Desethylene Levofloxacin | An impurity of Levofloxacin, which is as efficacious as or more efficacious than that with ciprofloxacin in systemic as well as pyelonephritis infections in mice. Group: Pharmaceutical. CAS No. 151250-76-9. Pack Sizes: 10 mg. Product ID: B2694-473742. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N, N-diethyl-2- ( (6-methylpyridin-2-yl) methylene) hydrazinecarbothioamide | N, N-diethyl-2- ( (6-methylpyridin-2-yl) methylene) hydrazinecarbothioamide, a chemically-complex compound, is gaining recognition in biomedicine as a viable drug candidate for treating a range of ailments. Notably, research suggests that it possesses considerable anti-inflammatory, analgesic, and antioxidant activity that could hold promise in combatting conditions such as arthritis and other inflammatory disorders. Nevertheless, comprehensive studies are necessary to ascertain its optimal therapeutic capacity. Group: Pharmaceutical. CAS No. 210700-64-4. Pack Sizes: 10 mg. Product ID: B0001-284864. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N,N'-Diethyl-N''-isopropyl-1,3,5-triazine-2,4,6-triamine | N,N'-Diethyl-N''-isopropyl-1,3,5-triazine-2,4,6-triamine, also called 2-Ethylaminoatrazine, under the IUPAC name 2-Ethylaminoatrazine, can be used as insecticide and herbicide. Uses: Insecticide; herbicide. Group: Pharmaceutical. CAS No. 30360-19-1. Pack Sizes: 1 g. Product ID: B0001-105664. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N,N'-Difurfuryloxamide | N,N'-Difurfuryloxamide, an organic compound of paramount significance used as a crucial forerunner in the creation of sundry medicines and pharmaceuticals. Distinguished by its notable anti-inflammatory and antimicrobial traits, it exhibits extensive promise as an agent amenable for treating multiple ailments like gingivitis and periodontitis. Group: Pharmaceutical. CAS No. 69010-90-8. Pack Sizes: 50 mg. Product ID: B0001-284780. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N,N'-Dimethyl-2,7-diazapyrenium difluoroborate | N,N'-Dimethyl-2,7-diazapyrenium difluoroborate (CAS# 21178-14-3 ) is a useful research chemical. Group: Pharmaceutical. CAS No. 21178-14-3. Pack Sizes: 50 mg. Product ID: B0001-057667. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N,N-Dimethyldecylamine N-oxide | N,N-Dimethyldecylamine N-oxide, commonly known as a tertiary amine oxide, is a surfactant used extensively in scientific research due to its unique properties as both a nonionic surfactant and a stabilizing agent in various aqueous and non-aqueous systems. Group: Pharmaceutical. CAS No. 2605-79-0. Pack Sizes: 10 g. Product ID: B1370-060892. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.